Ophthalmology · Westminster, CA
NPI
1477574200
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
9061 Bolsa Ave Ste 105
Westminster, CA, 92683
Phone (714) 899-5670
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.0M
12,614 services
Medicare patients, 2024
2,487
Average age 76
Drug cost, 2024
$7.2M
29,563 prescriptions
Company payments, 2025
$2,999
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cuong-Dung T DO was code 92012 (ophthalmological e&m), 2,693 times for 1,518 patients. In total Cuong-Dung T DO billed 12,614 services in 63 codes, and Medicare paid $1.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 2,693 | 1,518 | $84.32 | $227K |
| 92014 Ophthalmological E&M | Office | 1,775 | 1,669 | $118.44 | $210K |
| 92133 Computerized Ophthalmic Imaging | Office | 1,296 | 1,275 | $33.37 | $43K |
| 92020 Ophthalmological E&M | Office | 1,259 | 1,245 | $25.29 | $32K |
| 92083 Vision, Hearing, and Speech Services | Office | 830 | 823 | $60.16 | $50K |
| 92134 Computerized Ophthalmic Imaging | Office | 734 | 536 | $37.51 | $28K |
| 92250 Angiography | Office | 714 | 711 | $34.12 | $24K |
| 92004 Ophthalmological E&M | Office | 361 | 361 | $136.77 | $49K |
| 92136 Ultrasound - Nonspecific | Office | 283 | 237 | $40.52 | $11K |
| 67820 Eye | Office | 275 | 170 | $19.09 | $5,249 |
| 67028 Intravitreal Injection | Office | 250 | 79 | $105.65 | $26K |
| 92025 Test - Miscellaneous | Office | 242 | 240 | $33.49 | $8,104 |
| J9035 Injection, bevacizumab, 10 mg | Office | 240 | 75 | $57.50 | $14K |
| 66984 Cataract Surgery | Facility | 198 | 169 | $500.82 | $99K |
| 68761 Eye | Office | 162 | 99 | $111.93 | $18K |
By year: 2022 $626K for 8,389 services; 2023 $870K for 11,345 services; 2024 $1.0M for 12,614 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cuong-Dung T DO prescribed most often to Medicare patients was Vyzulta (Latanoprostene Bunod), with 3,865 prescriptions and refills. In total Cuong-Dung T DO wrote 29,563 Medicare prescriptions that cost $7.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyzulta Latanoprostene Bunod | 3,865 | 4,258 | 490 | $1.0M |
| Lumigan Bimatoprost | 2,973 | 3,262 | 461 | $769K |
| Latanoprost Generic | 2,780 | 3,354 | 547 | $18K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 2,328 | 3,988 | 467 | $40K |
| Azelastine Hcl Generic | 2,127 | 2,422 | 505 | $38K |
| Restasis Cyclosporine | 1,650 | 1,794 | 304 | $1.1M |
| Timolol Maleate Generic | 1,506 | 2,511 | 334 | $9,560 |
| Cyclosporine Generic | 1,362 | 1,590 | 289 | $427K |
| Xiidra Lifitegrast | 1,209 | 1,380 | 227 | $887K |
| Prednisolone Acetate Generic | 942 | 1,440 | 619 | $40K |
| Tyrvaya Varenicline Tartrate | 759 | 819 | 125 | $502K |
| Alrex Loteprednol Etabonate | 747 | 774 | 219 | $227K |
| Combigan Brimonidine Tartrate/Timolol | 632 | 679 | 96 | $133K |
| Rhopressa Netarsudil Mesylate | 610 | 692 | 111 | $205K |
| Miebo Perfluorohexyloctane/Pf | 602 | 627 | 151 | $468K |
Brand drugs: 18,775 claims; generic drugs: 10,788 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cuong-Dung T DO $2,999 ($2,999 in general payments such as food, travel and fees) from 12 companies. The largest payer was Alcon Vision LLC with $888.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 23 | $888 |
| Abbvie Inc. ABBV | 17 | $582 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $535 |
| Amgen Inc. AMGN | 23 | $356 |
| Bausch & Lomb Americas Inc. BLCO | 19 | $260 |
| Mallinckrodt Hospital Products Inc. | 9 | $147 |
| Oyster Point Pharma, Inc. | 5 | $123 |
| Dompe US, Inc. | 1 | $24.93 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $22.99 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $21.77 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.